MACROVIC powder for oral solution sachet Australia - English - Department of Health (Therapeutic Goods Administration)

macrovic powder for oral solution sachet

arrotex pharmaceuticals pty ltd - macrogol 3350, quantity: 13125 mg; sodium chloride, quantity: 350.7 mg; potassium chloride, quantity: 46.6 mg; sodium bicarbonate, quantity: 178.5 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

Macrovic 13.7 g or. sol. (pwdr.) sachet Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

macrovic 13.7 g or. sol. (pwdr.) sachet

strides pharma ltd. - macrogol 3350 13125 mg; sodium chloride 350,7 mg; sodium hydrogen carbonate 178,5 mg; potassium chloride 46,6 mg - powder for oral solution - 13.7 g - macrogol 3350 13125 mg; sodium chloride 350.7 mg; sodium bicarbonate 178.5 mg; potassium chloride 46.6 mg - macrogol, combinations

Macrovic Junior 6.9 g or. sol. (pwdr.) sachet Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

macrovic junior 6.9 g or. sol. (pwdr.) sachet

strides pharma ltd. - macrogol 3350 6562,5 mg; sodium chloride 175,35 mg; sodium hydrogen carbonate 89,25 mg; potassium chloride 23,3 mg - powder for oral solution - 6,9 g - macrogol 3350 6562.5 mg; sodium chloride 175.35 mg; sodium bicarbonate 89.25 mg; potassium chloride 23.3 mg - macrogol, combinations

Macrogol + Electrolytes AB 13.7 g or. sol. (pwdr.) sachet Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

macrogol + electrolytes ab 13.7 g or. sol. (pwdr.) sachet

aurobindo sa-nv - macrogol 13,125 g; potassium chloride 0,0466 g; sodium hydrogen carbonate 0,1785 g; sodium chloride 0,3507 g - powder for oral solution - 13,7 g - macrogol 3350 13.125 g; sodium chloride 0.351 g; potassium chloride 0.047 g; sodium bicarbonate 0.179 g - macrogol, combinations

Macrogol AB 4 g or. sol. (pwdr.) sachet Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

macrogol ab 4 g or. sol. (pwdr.) sachet

aurobindo sa-nv - macrogol 4000 mg - powder for oral solution in sachet - 4 g - macrogol 4000 4000 mg - macrogol

Macrogol AB 10 g or. sol. (pwdr.) sachet Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

macrogol ab 10 g or. sol. (pwdr.) sachet

aurobindo sa-nv - macrogol 10000 mg - powder for oral solution in sachet - 10 g - macrogol 4000 10000 mg - macrogol

ZOMACTON 10 MG Israel - English - Ministry of Health

zomacton 10 mg

ferring pharmaceuticals ltd - somatropin - powder and solvent for solution for injection - somatropin 10 mg - somatropin - somatropin - children :short stature due to inadequate or failed secretion of pituitary growth hormone or turner's syndrome. short stature in children with renal insufficiency.

ZOMACTON Powder and Solvent for Solution for Injection 4 mg Singapore - English - HSA (Health Sciences Authority)

zomacton powder and solvent for solution for injection 4 mg

ferring pharmaceuticals private limited - somatropin - injection, powder, for solution - 4 mg - somatropin 4 mg

MACROVIC JUNIOR powder for oral solution sachet Australia - English - Department of Health (Therapeutic Goods Administration)

macrovic junior powder for oral solution sachet

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; macrogol 3350, quantity: 6562.5 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.